ID   DPYL3_RAT               Reviewed;         570 AA.
AC   Q62952; Q8K4H3; Q91XM8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   02-OCT-2024, entry version 176.
DE   RecName: Full=Dihydropyrimidinase-related protein 3;
DE            Short=DRP-3;
DE   AltName: Full=Collapsin response mediator protein 4;
DE            Short=CRMP-4;
DE   AltName: Full=TOAD-64/Ulip/CRMP;
DE   AltName: Full=TUC-4b;
GN   Name=Dpysl3; Synonyms=Crmp4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, SUBCELLULAR LOCATION,
RP   DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, ALTERNATIVE SPLICING, AND
RP   INTERACTION WITH SYNAPTIC VESICLE PROTEIN 2 AND INTERSECTIN.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=12684468; DOI=10.1523/jneurosci.23-07-02815.2003;
RA   Quinn C.C., Chen E., Kinjo T.G., Kelly G., Bell A.W., Elliott R.C.,
RA   McPherson P.S., Hockfield S.;
RT   "TUC-4b, a novel TUC family variant, regulates neurite outgrowth and
RT   associates with vesicles in the growth cone.";
RL   J. Neurosci. 23:2815-2823(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Elliott R.C., Parent J.M., Lowenstein D.H.;
RT   "Adult-specific collapsin response mediator protein 4 (CRMP4) transcripts
RT   correlate with widespread CRMP4 expression in normal and epileptic adult
RT   rats.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-358 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8815901; DOI=10.1523/jneurosci.16-19-06197.1996;
RA   Wang L., Strittmatter S.M.;
RT   "A family of rat CRMP genes is differentially expressed in the nervous
RT   system.";
RL   J. Neurosci. 16:6197-6207(1996).
RN   [4]
RP   PROTEIN SEQUENCE OF 532-550, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [5]
RP   SUBUNIT.
RX   PubMed=9375656; DOI=10.1046/j.1471-4159.1997.69062261.x;
RA   Wang L.H., Strittmatter S.M.;
RT   "Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase.";
RL   J. Neurochem. 69:2261-2269(1997).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=19343716; DOI=10.1002/pmic.200800664;
RA   Maurya D.K., Sundaram C.S., Bhargava P.;
RT   "Proteome profile of the mature rat olfactory bulb.";
RL   Proteomics 9:2593-2599(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-509; THR-514 AND SER-522,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Necessary for signaling by class 3 semaphorins and subsequent
CC       remodeling of the cytoskeleton. Plays a role in axon guidance, neuronal
CC       growth cone collapse and cell migration. {ECO:0000269|PubMed:12684468}.
CC   -!- SUBUNIT: Homotetramer, and heterotetramer with CRMP1, DPYSL2, DPYSL4 or
CC       DPYSL5 (PubMed:9375656). Interacts with synaptic vesicle protein 2 and
CC       SH3A domain of intersectin (PubMed:12684468). Interacts with FLNA (By
CC       similarity). {ECO:0000250|UniProtKB:Q14195,
CC       ECO:0000269|PubMed:12684468, ECO:0000269|PubMed:9375656}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19343716}. Cell
CC       projection, growth cone {ECO:0000269|PubMed:12684468}. Note=Colocalizes
CC       with synaptic vesicle protein 2 in the central region of the growth
CC       cone. {ECO:0000269|PubMed:12684468}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=TUC-4b;
CC         IsoId=Q62952-1; Sequence=Displayed;
CC       Name=2; Synonyms=TUC-4a;
CC         IsoId=Q62952-2; Sequence=VSP_016557;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is expressed in growth cones. Up-
CC       regulated in motor neurons during axonal regeneration after sciatic
CC       nerve lesion. Overexpression of isoform 2 increased neurite extension
CC       and branching. Isoform 1 is expressed throughout neurons and their
CC       axons. {ECO:0000269|PubMed:12684468}.
CC   -!- DEVELOPMENTAL STAGE: At 17 dpc, isoform 2 is expressed in the CNS and
CC       PNS. Isoform 2 is expressed at high levels in the dorsal root ganglia,
CC       trigeminal ganglia, and throughout the spinal cord with the highest
CC       level in the ventral horn. {ECO:0000269|PubMed:12684468}.
CC   -!- PTM: Phosphorylation on Ser-522 by DYRK2 promotes subsequent
CC       phosphorylation on Thr-509, Thr-514 and Ser-518 by GSK3. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the metallo-dependent hydrolases superfamily.
CC       Hydantoinase/dihydropyrimidinase family. {ECO:0000305}.
CC   -!- CAUTION: Lacks most of the conserved residues that are essential for
CC       binding the metal cofactor and hence for dihydropyrimidinase activity.
CC       Its enzyme activity is therefore unsure. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF398465; AAM73758.1; -; mRNA.
DR   EMBL; AF389425; AAK64497.1; -; mRNA.
DR   EMBL; U52104; AAB03282.1; -; mRNA.
DR   RefSeq; NP_037066.1; NM_012934.1. [Q62952-1]
DR   RefSeq; XP_006254732.1; XM_006254670.3.
DR   AlphaFoldDB; Q62952; -.
DR   SMR; Q62952; -.
DR   BioGRID; 247453; 2.
DR   IntAct; Q62952; 3.
DR   MINT; Q62952; -.
DR   STRING; 10116.ENSRNOP00000025880; -.
DR   MEROPS; M38.976; -.
DR   GlyGen; Q62952; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q62952; -.
DR   PhosphoSitePlus; Q62952; -.
DR   jPOST; Q62952; -.
DR   PaxDb; 10116-ENSRNOP00000025880; -.
DR   Ensembl; ENSRNOT00000025880.6; ENSRNOP00000025880.2; ENSRNOG00000018992.8. [Q62952-2]
DR   Ensembl; ENSRNOT00000087876.2; ENSRNOP00000070679.1; ENSRNOG00000018992.8. [Q62952-1]
DR   Ensembl; ENSRNOT00055031894; ENSRNOP00055025791; ENSRNOG00055018708. [Q62952-1]
DR   Ensembl; ENSRNOT00060019906; ENSRNOP00060015637; ENSRNOG00060011758. [Q62952-1]
DR   Ensembl; ENSRNOT00065032236; ENSRNOP00065025744; ENSRNOG00065019150. [Q62952-1]
DR   GeneID; 25418; -.
DR   KEGG; rno:25418; -.
DR   UCSC; RGD:2410; rat. [Q62952-1]
DR   AGR; RGD:2410; -.
DR   CTD; 1809; -.
DR   RGD; 2410; Dpysl3.
DR   eggNOG; KOG2584; Eukaryota.
DR   GeneTree; ENSGT01030000234527; -.
DR   InParanoid; Q62952; -.
DR   OMA; WVTAEVT; -.
DR   OrthoDB; 1772494at2759; -.
DR   PhylomeDB; Q62952; -.
DR   TreeFam; TF314706; -.
DR   Reactome; R-RNO-399956; CRMPs in Sema3A signaling.
DR   PRO; PR:Q62952; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000018992; Expressed in testis and 19 other cell types or tissues.
DR   GO; GO:0044297; C:cell body; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070382; C:exocytic vesicle; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0031941; C:filamentous actin; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0045202; C:synapse; IDA:SynGO.
DR   GO; GO:0035374; F:chondroitin sulfate binding; IDA:RGD.
DR   GO; GO:0031005; F:filamin binding; ISO:RGD.
DR   GO; GO:0016812; F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:RGD.
DR   GO; GO:0051764; P:actin crosslink formation; IDA:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IEP:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:UniProtKB.
DR   CDD; cd01314; D-HYD; 1.
DR   Gene3D; 3.20.20.140; Metal-dependent hydrolases; 1.
DR   Gene3D; 2.30.40.10; Urease, subunit C, domain 1; 1.
DR   InterPro; IPR006680; Amidohydro-rel.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   InterPro; IPR050378; Metallo-dep_Hydrolases_sf.
DR   NCBIfam; TIGR02033; D-hydantoinase; 1.
DR   PANTHER; PTHR11647:SF57; DIHYDROPYRIMIDINASE-RELATED PROTEIN 3; 1.
DR   PANTHER; PTHR11647; HYDRANTOINASE/DIHYDROPYRIMIDINASE FAMILY MEMBER; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; Composite domain of metallo-dependent hydrolases; 2.
DR   SUPFAM; SSF51556; Metallo-dependent hydrolases; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Cytoplasm;
KW   Direct protein sequencing; Phosphoprotein; Reference proteome.
FT   CHAIN           1..570
FT                   /note="Dihydropyrimidinase-related protein 3"
FT                   /id="PRO_0000165919"
FT   REGION          506..570
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        511..548
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         259
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14195"
FT   MOD_RES         431
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   MOD_RES         499
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   MOD_RES         509
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         514
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         518
FT                   /note="Phosphoserine; by GSK3"
FT                   /evidence="ECO:0000250|UniProtKB:Q14195"
FT   MOD_RES         522
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         536
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   MOD_RES         539
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   MOD_RES         541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   MOD_RES         543
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62188"
FT   VAR_SEQ         1..13
FT                   /note="MSYQGKKNIPRIT -> MASGRRGWDSSHEDDLPVYLARPGTTDQVPRQKYG
FT                   GMFCNVEGAFESKTLDFDALSVGQRGAKTPRSSQGSGRGAGNRPGVEGDTRRGPGREES
FT                   REPVPESPKPAGVEIRSATGKEVLQNLGPKDK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12684468"
FT                   /id="VSP_016557"
FT   MOD_RES         Q62952-2:101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   570 AA;  61967 MW;  4EF1981CDE9A8708 CRC64;
     MSYQGKKNIP RITSDRLLIK GGRIVNDDQS FYADIYMEDG LIKQIGDNLI VPGGVKTIEA
     NGKMVMPGGI DVHTHFQMPY KGMTTVDDFF QGTKAALAGG TTMIIDHVVP EPESSLTEAY
     EKWREWADGK SCCDYALHVD ITHWNDSVKQ EVQNLSKEKG VNSFMVYMAY KDLYQVSNTE
     LYEIFTCLGE LGAIAQVHAE NGDIIAQEQA RMLEMGITGP EGHVLSRPEE LEAEAVFRAI
     TVASQTNCPL YVTKVMSKSA ADLISQARKK GNVVFGEPIT ASLGIDGTHY WSKNWAKAAA
     FVTSPPLSPD PTTPDYINSL LASGDLQLSG SAHCTFSTAQ KAIGKDNFTA IPEGTNGVEE
     RMSVIWDKAV ATGKMDENQF VAVTSTNAAK IFNLYPRKGR IAVGSDSDLV IWDPDAVKIV
     SAKNHQSVAE YNIFEGMELR GAPLVVICQG KIMLEDGNLH VTQGAGRFIP CSPFSDYVYK
     RIKARRKMAD LHAVPRGMYD GPVFDLTTTP KGGTPAGSTR GSPTRPNPPV RNLHQSGFSL
     SGTQVDEGVR SASKRIVAPP GGRSNITSLS
//
